Bristol-Myers Squibb (Malaysia)Sdn Bhd
- A01 - Preparados estomatológicos
- KENALOG IN ORABASE oromucosal paste 0.1%
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MYCOSTATIN oral suspension 100 000 IU/ml
- C07 - Betabloqueantes
- SOTACOR tablet 80 mg
- C10 - Agentes modificadores de los lípidos
- PRAVACHOL tablet 20 mg
- PRAVACHOL tablet 40 mg
- H02 - Corticosteroides para uso sistémico
- FLORINEF tablet 0.1 mg
- J01 - Antibacterianos para uso sistémico
- MAXIPIME powder for solution for injection 1 g
- MAXIPIME powder for solution for injection 2 g
- MAXIPIME powder for solution for injection 500 mg
- J02 - Antimicóticos de uso sistémico
- FUNGIZONE powder for solution for infusion 50 mg
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- REYATAZ capsule, hard 100 mg
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- VIDEX EC gastro-resistant capsule, hard 250 mg
- VIDEX EC gastro-resistant capsule, hard 400 mg
- VIDEX PAED powder for oral solution 2 g
- L01 - Antineoplásicos
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- TAXOL concentrate for solution for infusion 100 mg/16.7 ml
- TAXOL concentrate for solution for infusion 30 mg/5 ml
- L02 - Terapia endocrina
- MEGACE tablet 160 mg
- N05 - Psicolépticos
- ABILIFY tablet 10 mg
- ABILIFY tablet 15 mg
- S02 - Otológicos
- KENACOMB ear drops, solution